Takeda News, Takeda Quote, TAK Quote

Takeda (NY:TAK) Delayed: 15.77 +0.09 (0.57%)

Prev. Close

$15.68

Today 6M 1Y 5Y

Open

$15.82

52 Wk High

$0.55

52 Wk Low

$0.55

Day High

$15.83

Day Low

$15.74

P/E

N/A

EPS

$-0.20

Volume

68,884

Friends, Peers and Foes (?): PTGX, 4502:JP, 6IB, IVBIY, ABBV (more...)

ALERTS | RSS

Jun 11, 2026 07:00 AM Takeda's zasocitinib beats deucravacitinib in psoriasis study
Jun 11, 2026 07:00 AM Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations
Jun 9, 2026 04:30 PM FDA accepts Takeda's application for pediatric ENTYVIO treatment
Jun 9, 2026 04:30 PM U.S. FDA Accepts Takeda's Application for Intravenous ENTYVIO® (vedolizumab) in Pediatric Ulcerative Colitis and Crohn's Disease
Jun 9, 2026 06:10 AM Form 6-K TAKEDA PHARMACEUTICAL For: Jun 09
Jun 5, 2026 06:30 AM Form 6-K TAKEDA PHARMACEUTICAL For: Jun 05
Jun 5, 2026 06:28 AM Form 6-K TAKEDA PHARMACEUTICAL For: Jun 05
Jun 1, 2026 06:07 AM Form 6-K TAKEDA PHARMACEUTICAL For: Jun 01
May 26, 2026 06:19 AM Takeda Pharmaceutical (4502:JP) (TAK) PT Raised to JPY7,900 at Citi
May 26, 2026 06:14 AM Form 6-K TAKEDA PHARMACEUTICAL For: May 26

Entities mentioned with TAK

View All Entities